随着基因检测技术快速发展,深入探究冠心病相关基因及其多态性对早期筛查、个体化预防、靶向药物治疗等至关重要。本文基于国内外的研究进展,综述了不同类型的基因多态性与冠心病之间的关系,为开展对易感人群的筛查、预防及治疗提供新思路。
With the rapid development of gene testing technology, in-depth study of CHD related genes and their polymorphisms is of great importance for early screening, individualized prevention and targeted drug therapy. Based on the research progress at home and abroad, this paper reviews the relationship between different types of gene polymorphism and coronary heart disease. It provides new ideas for screening, prevention and treatment of susceptible population.
With the rapid development of gene testing technology, in-depth study of CHD related genes and their polymorphisms is of great importance for early screening, individualized prevention and targeted drug therapy. Based on the research progress at home and abroad, this paper reviews the relationship between different types of gene polymorphism and coronary heart disease. It provides new ideas for screening, prevention and treatment of susceptible population.
Keywords:Gene Polymorphism, Coronary Heart Disease (CHD), Susceptibility, The Curative Effect
参考文献References《中国心血管健康与疾病报告2020》概述[J]. 中国心血管病研究, 2021, 19(7): 582-590.Feng, Y., Chen, L., Liu, Y., et al. (2020) Association between Apolipoprotein B XbaI Polymorphisms and Coronary Heart Disease: A Meta-Analysis. BMC Cardiovascular Disorders, 20, Article No. 265.
<br>https://doi.org/10.1186/s12872-020-01545-7Yu, D., Ma, L., Zhou, J., et al. (2020) Influence of Genotype on Antiplatelet Treatment Outcomes after Percutaneous Coronary Intervention in Patients with Coronary Heart Disease. Experimental and Therapeutic Medicine, 19, 3411-3418.
<br>https://doi.org/10.3892/etm.2020.8592McPherson, R. and Tybjaerg-Hansen, A. (2016) Genetics of Coronary Artery Disease. Circulation Research, 118, 564-578. <br>https://doi.org/10.1161/CIRCRESAHA.115.306566纪昕, 岳晓乐, 赵丹丹, 等. 同型半胱氨酸与动脉粥样硬化患者血管内皮细胞损伤相关性[J]. 标记免疫分析与临床, 2017, 24(1): 73-76.Yang, B., Liu, Y., Li, Y., et al. (2013) Geographical Distribution of MTHFR C677T, A1298C and MTRR A66G Gene Polymorphisms in China: Findings from 15357 Adults of Han Nationality. PLoS ONE, 8, e57917.
<br>https://doi.org/10.1371/journal.pone.0057917沈静, 张红琴, 马蔡昀, 等. MTHFR基因C667T和A1298C多态位点和高同型半胱氨酸与冠心病的相关性研究[J]. 标记免疫分析与临床, 2020, 27(2): 219-223+241.陈宁, 孙婷, 陈明. MTHFR基因C677T多态性与冠状动脉支架植入术后再狭窄的相关性研究[J]. 中国循证心血管医学杂志, 2021, 13(6): 734-737.李柳, 张晓婵, 茹琪, 等. 四氢叶酸还原酶基因多态性与冠心病严重程度的相关性[J]. 昆明医科大学学报, 2021, 42(5): 138-142.马芳芳, 谢华斌. MTHFR基因C677T多态性与中国人群冠心病相关性的Meta分析[J]. 临床心血管病杂志, 2018, 34(10): 965-969.Wu, K., Zhang, S., Guan, Z., et al. (2021) Methylenetetrahydrofolate Reductase Gene Polymorphism C677T Is Associated with Increased Risk of Coronary Heart Disease in Chinese Type 2 Diabetic Patients. Chinese Medical Sciences Journal, 36, 103-109.张晶, 丛洪良, 曹路, 等. 亚甲基四氢叶酸还原酶A1298C多态性与高同型半胱氨酸血症的相关性[J]. 中华老年心脑血管病杂志, 2017, 19(11): 1166-1169.Saleheen, D., Zhao, W., Young, R., et al. (2017) Loss of Cardioprotective Effects at the ADAMTS7 Locus as a Result of Gene-Smoking Interactions. Circulation, 135, 2336-2353.Song, K.H., Cha, S., Yu, S.-G., et al. (2013) Association of Apolipoprotein A5 Gene 1131TC Polymorphism with the Risk of Metabolic Syndrome in Korean Subjects. BioMed Research International, 2013, Article ID: 585134.
<br>https://doi.org/10.1155/2013/585134Bogari, N.M., Aljohani, A., Amin, A.A., et al. (2019) A Genetic Variant c.553G > T (rs2075291) in the Apolipoprotein A5 Gene Is Associated with Altered Triglycerides Levels in Coronary Artery Disease (CAD) Patients with Lipid Lowering Drug. BMC Cardiovascular Disorders, 19, Article No. 2. <br>https://doi.org/10.1186/s12872-018-0965-3Abd El-Aziz, T.A. and Mohamed, R.H. (2016) LDLR, ApoB and ApoE Genes Polymorphisms and Classical Risk Factors in Premature Coronary Artery Disease. Gene, 590, 263-269. <br>https://doi.org/10.1016/j.gene.2016.05.032Chen, Y., Lin, M., Liang, Y., et al. (2016) Association between Apolipoprotein B XbaI Polymorphism and Coronary Heart Disease in Han Chinese Population: A Meta-Analysis. Genetic Testing and Molecular Biomarkers, 20, 304-311.
<br>https://doi.org/10.1089/gtmb.2015.0126Afroze, D., Yousuf, A., Tramboo, N., et al. (2016) ApoE Gene Polymorphism and Its Relationship with Coronary Artery Disease in Ethnic Kashmiri Population. Clinical and Experimental Medicine, 16, 551-556.
<br>https://doi.org/10.1007/s10238-015-0389-7Lv, P., Zheng, Y., Huang, J., et al. (2020) Apolipoprotein E Association of Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-Intensity Statins. Neuropsychiatric Disease and Treatment, 16, 2459-2466. <br>https://doi.org/10.2147/NDT.S265194Yousuf, F. and Iqbal, M. (2015) Review: Apolipoprotein E (Apo E) Gene Polymorphism and Coronary Heart Disease in Asian Populations. Pakistan Journal of Pharmaceutical Sciences, 28, 1439-1444.Luo, Z., Pu, L., Muhammad, I., et al. (2018) Associations of the PON1 rs662 Polymorphism with Circulating Oxidized Low-Density Lipoprotein and Lipid Levels: A Systematic Review and Meta-Analysis. Lipids in Health and Disease, 17, Article No. 281. <br>https://doi.org/10.1186/s12944-018-0937-8Deng, Z., Xiang, H. and Gao, W. (2020) Significant Association between Paraoxonase1 rs662 Polymorphism and Coronary Heart Disease: A Meta-Analysis in the Chinese Population. Herz, 45, 347-355.
<br>https://doi.org/10.1007/s00059-018-4737-8Chistiakov, D., Melnichenko, A., Orekhov, A., et al. (2017) Paraoxonase and Atherosclerosis-Related Cardiovascular Diseases. Biochimie, 132, 19-27. <br>https://doi.org/10.1016/j.biochi.2016.10.010González-Castro, T.B., Tovilla-Zárate, C.A., Juárez-Rojop, I.E., et al. (2018) PON2 and PPARG Polymorphisms as Biomarkers of Risk for Coronary Heart Disease. Biomarkers in Medicine, 12, 287-297.
<br>https://doi.org/10.2217/bmm-2017-0227Zhang, C., Peng, W., Wang, M., et al. (2010) Studies on Protective Effects of Human Paraoxonases 1 and 3 on Atherosclerosis in Apolipoprotein E Knockout Mice. Gene Therapy, 17, 626-633. <br>https://doi.org/10.1038/gt.2010.11Li, Y., Zhu, J. and Ding, J.Q. (2015) VKORC1 rs2359612 and rs9923231 Polymorphisms Correlate with High Risks of Cardiovascular and Cerebrovascular Diseases. Genetics and Molecular Research, 14, 14731-14744.
<br>https://doi.org/10.4238/2015.November.18.38Du, J., Zhang, Z., Ge, Y., et al. (2015) VKORC1 and CD-14 Genetic Polymorphisms Associate with Susceptibility to Cardiovascular and Cerebrovascular Diseases. International Journal of Clinical and Experimental Medicine, 8, 20444-20453.Turgut Cosan, D., Yazıcı, H., Colak, E., et al. (2017) Susceptiveness of Vitamin K epOxide Reductase Complex Subunit 1 Gene Polymorphism in Essential Hypertension. Genetic Testing and Molecular Biomarkers, 21, 292-297.
<br>https://doi.org/10.1089/gtmb.2016.0311张艳娇, 杨雪婷, 李烨, 等. 云南地区冠心病患者CYP2C19基因多态性分布研究[J]. 中国医院药学杂志, 2021, 41(1): 42-45.Huang, B., Cui, D., Ren, Y., et al. (2017) Effect of Cytochrome P450 2C19*17 Allelic Variant on Cardiovascular and Cerebrovascular Outcomes in Clopidogrel-Treated Patients: A Systematic Review and Meta-Analysis. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences, 22, 109.
<br>https://doi.org/10.4103/jrms.JRMS_590_16Claassens, D.M.F., Vos, G.J.A., Bergmeijer, T.O., et al. (2019) A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI. The New England Journal of Medicine, 381, 1621-1631. <br>https://doi.org/10.1056/NEJMoa1907096Zhang, Y., Zhou, X., Ji, W., et al. (2019) Association between CYP2C19*2/*3 Polymorphisms and Coronary Heart Disease. Current Medical Science, 39, 44-51. <br>https://doi.org/10.1007/s11596-019-1998-2Hou, X., Han, W., Gan, Q., et al. (2018) CYP2C19 and ABCB1 Genetic Polymorphisms Correlate with the Recurrence of Ischemic Cardiovascular Adverse Events after Clopidogrel Treatment. Journal of Clinical Laboratory Analysis, 32, e22369. <br>https://doi.org/10.1002/jcla.22369Sibbing, D., Aradi, D., Alexopoulos, D., et al. (2019) Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions, 12, 1521-1537. <br>https://doi.org/10.1016/j.jcin.2019.07.011Wang, Y., Du, X., Zhao, R., et al. (2021) Association of APOE Polymorphisms with Lipid-Lowering Efficacy of Statins in Atherosclerotic Cardiovascular Diseases. Annals—Academy of Medicine Singapore, 50, 474-480.
<br>https://doi.org/10.47102/annals-acadmedsg.2020505Jabr, R., Gharaibeh, M., Zayed, A., et al. (2021) The Association between Apolipoprotein E Polymorphism and Response to Statins in Group of Hyperlipidemic Patients. Endocrine, Metabolic &Immune Disorders Drug Targets, 21, 720-725. <br>https://doi.org/10.2174/1871530320666200705211656范春煜, 苏昊, 付强, 等. 他汀类药物代谢相关ApoE基因多态性与冠状动脉介入术后再狭窄的相关性研究[J]. 中国循证心血管医学杂志, 2020, 12(6): 703-707.Zubiaur, P., Benedicto, M., Villapalos-García, G., et al. (2021) SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability. Journal of Personalized Medicine, 11, 204.
<br>https://doi.org/10.3390/jpm11030204Zhang, D., Ding, Y., Wang, X., et al. (2020) Effects of ABCG2 and SLCO1B1 Gene Variants on Inflammation Markers in Patients with Hypercholesterolemia and Diabetes Mellitus Treated with Rosuvastatin. European Journal of Clinical Pharmacology, 76, 939-946. <br>https://doi.org/10.1007/s00228-020-02882-4Lu, B., Sun, L., Seraydarian, M., et al. (2021) Effect of SLCO1B1 T521C on Statin-Related Myotoxicity with Use of Lovastatin and Atorvastatin. Clinical Pharmacology and Therapeutics, 110, 733-740. <br>https://doi.org/10.1002/cpt.2337